Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 56 | 50 | −6 |
| Shares | 25.2M | 27.2M | +1.98M (+7.8%) |
| Value | $20.3M | $21.5M | +$1.21M (+6.0%) |
New holders (5)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 91,951 | $73.0K | 0.01% |
| IPG Investment Advisors LLC | 57,385 | $45.0K | 0.01% |
| Rossmore Private Capital | 17,500 | $14.0K | 0.00% |
| Magnus Financial Group LLC | 15,000 | $12.0K | 0.00% |
| Venture Visionary Partners LLC | 4,813 | $3.80K | 0.00% |
Sold out (11)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Sandhill Capital Partners LLC | 50,000 | $40.0K |
| First Republic Investment Management, Inc. | 31,720 | $26.0K |
| Integrated Wealth Concepts LLC | 25,100 | $20.0K |
| Raymond James & Associates | 22,000 | $18.0K |
| Kovitz Investment Group Partners, LLC | 15,000 | $12.0K |
| Rafferty Asset Management, LLC | 12,839 | $10.0K |
| AE Wealth Management LLC | 11,889 | $10.0K |
| Fore Capital, LLC | 10,000 | $8.00K |
| FMR LLC | 7,400 | $6.00K |
| Tower Research Capital LLC (TRC) | 5,607 | $5.00K |
| Lansing Street Advisors | 750 | $1.00K |